The Journal of Immunology, Vol 156, Issue 11 4107-4113, Copyright © 1996 by American Association of Immunologists

ARTICLES

Inability to produce IL-6 is a functional feature of human germinal center B lymphocytes

N Burdin, L Galibert, P Garrone, I Durand, J Banchereau and F Rousset
Laboratory for Immunological Research, Schering-Plough, Dardilly, France.

In response to Ag encounter, B lymphocytes undergo a complex maturation process yielding phenotypically distinct subpopulations that are located in highly organized compartments of secondary lymphoid organs. This study describes the patterns of cytokine secretion of naive, memory, and germinal center (GC) human tonsillar B lymphocytes, activated either through CD40 or B cell receptor or with Staphylococcus aureus Cowan I particles. The three B cell subpopulations produced comparable levels of IL-10 and TNF-alpha, regardless of the stimulation pathway. Interestingly, activated GC B lymphocytes fail to express IL- 6, as determined both at mRNA and at protein levels, whereas both naive and memory B cells can be induced to secrete IL-6. Likewise, naive B lymphocytes undergoing dual ligation of CD40 and B cell receptor fail to express IL-6, since they acquire a GC-like phenotype. IL-6 receptors are up-regulated on both ex vivo-purified GC B lymphocytes and in vitro generated GC-like B cells, following CD40 activation. Consistent with this, addition of exogenous IL-6 sustains growth of CD40-stimulated GC B lymphocytes. Taken together, these results demonstrate that loss of IL-6 secretion is a functional characteristic of human GC B lymphocytes. The swap from an autocrine to a paracrine IL-6 response may permit a better control of B cell growth and differentiation during the germinal center reaction.

This article has been cited by other articles:

				D. T. Avery, V. L. Bryant, C. S. Ma, R. de Waal Malefyt, and S. G. Tangye IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-4 J. Immunol., August 1, 2008; 181(3): 1767 - 1779. [Abstract] [Full Text] [PDF]

				X. Lu, J. Chen, R. Malumbres, E. Cubedo Gil, D. M. Helfman, and I. S. Lossos HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration Blood, December 15, 2007; 110(13): 4268 - 4277. [Abstract] [Full Text] [PDF]

				K. L. Good, V. L. Bryant, and S. G. Tangye Kinetics of Human B Cell Behavior and Amplification of Proliferative Responses following Stimulation with IL-21 J. Immunol., October 15, 2006; 177(8): 5236 - 5247. [Abstract] [Full Text] [PDF]

				S. Ghosh, A. C. Steere, B. D. Stollar, and B. T. Huber In Situ Diversification of the Antibody Repertoire in Chronic Lyme Arthritis Synovium J. Immunol., March 1, 2005; 174(5): 2860 - 2869. [Abstract] [Full Text] [PDF]

				S. Reinartz, A. Hombach, S. Kohler, H. Schlebusch, D. Wallwiener, H. Abken, and U. Wagner Interleukin-6 Fused to an Anti-idiotype Antibody in a Vaccine Increases the Specific Humoral Immune Response against CA125+ (MUC-16) Ovarian Cancer Cancer Res., June 15, 2003; 63(12): 3234 - 3240. [Abstract] [Full Text] [PDF]

				S. Manoj, P. J. Griebel, L. A. Babiuk, and S. van Drunen Littel-van den Hurk Targeting with Bovine CD154 Enhances Humoral Immune Responses Induced by a DNA Vaccine in Sheep J. Immunol., January 15, 2003; 170(2): 989 - 996. [Abstract] [Full Text] [PDF]

				G. Jego, R. Bataille, and C. Pellat-Deceunynck Interleukin-6 is a growth factor for nonmalignant human plasmablasts Blood, March 15, 2001; 97(6): 1817 - 1822. [Abstract] [Full Text] [PDF]

				T. Ohtsuka, M. Hamada, G. Hiasa, O. Sasaki, M. Suzuki, Y. Hara, Y. Shigematsu, and K. Hiwada Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., February 1, 2001; 37(2): 412 - 417. [Abstract] [Full Text] [PDF]

				Z. Liu, S. Colpaert, G. R. D'Haens, A. Kasran, M. d. Boer, P. Rutgeerts, K. Geboes, and J. L. Ceuppens Hyperexpression of CD40 Ligand (CD154) in Inflammatory Bowel Disease and Its Contribution to Pathogenic Cytokine Production J. Immunol., October 1, 1999; 163(7): 4049 - 4057. [Abstract] [Full Text] [PDF]

				J. L. Schultze, S. Michalak, J. Lowne, A. Wong, M. H. Gilleece, J. G. Gribben, and L. M. Nadler Human Non-Germinal Center B Cell Interleukin (IL)-12 Production Is Primarily Regulated by T Cell Signals CD40 Ligand, Interferon gamma , and IL-10: Role of B Cells in the Maintenance of  T Cell Responses J. Exp. Med., January 4, 1999; 189(1): 1 - 12. [Abstract] [Full Text] [PDF]

				M. Kopf, S. Herren, M. V. Wiles, M. B. Pepys, and M. H. Kosco-Vilbois Interleukin 6 Influences Germinal Center Development and Antibody Production via a Contribution of C3 Complement Component J. Exp. Med., November 16, 1998; 188(10): 1895 - 1906. [Abstract] [Full Text] [PDF]

				B. Dubois, C. Massacrier, B. Vanbervliet, J. Fayette, F. Briere, J. Banchereau, and C. Caux Critical Role of IL-12 in Dendritic Cell-Induced Differentiation of Naive B Lymphocytes J. Immunol., September 1, 1998; 161(5): 2223 - 2231. [Abstract] [Full Text] [PDF]